...
首页> 外文期刊>Archives of disease in childhood. Fetal and neonatal edition >Propofol for endotracheal intubation in neonates: a dose-finding trial
【24h】

Propofol for endotracheal intubation in neonates: a dose-finding trial

机译:新生儿中用于气管插管的异丙酚:剂量调查

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective To find propofol doses providing effective sedation without side effects in neonates of different gestational ages (GA) and postnatal ages (PNA). Design and setting Prospective multicentere dose-finding study in 3 neonatal intensive care units. Patients Neonates with a PNA 28 days requiring non-emergency endotracheal intubation. Interventions Neonates were stratified into 8 groups based on GA and PNA. The first 5 neonates in every group received a dose of 1.0 mg/kg propofol. Based on sedative effect and side effects, the dose was increased or decreased in the next 5 patients until the optimal dose was found. Main outcome measures The primary outcome was the optimal single propofol starting dose that provides effective sedation without side effects in each age group. Results After inclusion of 91 patients, the study was prematurely terminated because the primary outcome was only reached in 13% of patients. Dose-finding was completed in 2 groups, but no optimal propofol dose was found. Effective sedation without side effects was achieved more often after a starting dose of 2.0 mg/kg (28%) than after 1.0 mg/kg (3%) and 1.5 mg/kg (9%). Propofol-induced hypotension occurred in 59% of patients. Logistic regression analyses showed that GA and PNA did not predict effective sedation or the occurrence of hypotension. Conclusions Effective sedation without side effects is difficult to achieve with propofol and the optimal dose in different age groups of neonates could not be determined. The sedative effect of propofol and the occurrence of hypotension are unpredictable and show large inter-individual variability in the neonatal population.
机译:目的寻找异丙酚剂量,提供有效的镇静,在不同妊娠期(GA)和产后期生(PNA)的新生儿中没有副作用。 3个新生强化护理单位设计与设定预期多必需剂量查找研究。患者用PNA的新生儿<28天,需要非急应气管内插管。干预新生儿基于GA和PNA分层为8组。每组中的前5个新生儿接受了1.0mg / kg异丙酚的剂量。基于镇静效应和副作用,在接下来的5名患者中,剂量增加或减少,直至发现最佳剂量。主要结果测量主要结果是最佳的单一类异丙酚起始剂量,可在每个年龄组中提供有效的镇静而没有副作用。结果包含91例患者后,研究过早终止,因为初级结​​果仅为13%的患者达到。剂量发现在2组中完成,但没有发现最佳的异丙酚剂量。在2.0mg / kg(28%)的起始剂量比1.0mg / kg(3%)和1.5mg / kg(9%)之后,更常见的镇静沉积物更常见于2.0mg / kg(28%)。 Proofol诱导的低血压发生在59%的患者中。 Logistic回归分析显示Ga和PNA没有预测有效的镇静或低血压的发生。结论没有副作用的有效镇静难以达到异丙酚,并且无法确定新生儿的不同年龄组中的最佳剂量。异丙酚的镇静作用和低血压的发生是不可预测的并且在新生儿群体中显示出大的间间变异性。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号